Difference between revisions of "Main Page"
m |
Binunair2002 (talk | contribs) |
||
| Line 22: | Line 22: | ||
|[[Myelofibrosis | Primary & secondary myelofibrosis]] | |[[Myelofibrosis | Primary & secondary myelofibrosis]] | ||
|[[Polycythemia vera | Polycythemia vera (PV)]] | |[[Polycythemia vera | Polycythemia vera (PV)]] | ||
| + | |[[ hypereosinophilic syndromes (HES)]] | ||
| + | |[[Mast cell diseases]] | ||
|- | |- | ||
|colspan="4" align="center" style="background-color:#FF0D00"| '''Mature B-, T-, and NK-cell neoplasms''' | |colspan="4" align="center" style="background-color:#FF0D00"| '''Mature B-, T-, and NK-cell neoplasms''' | ||
| Line 49: | Line 51: | ||
|[[Aplastic anemia]] | |[[Aplastic anemia]] | ||
|[[Autoimmune thrombocytopenic purpura (ITP)]] | |[[Autoimmune thrombocytopenic purpura (ITP)]] | ||
| − | |||
|[[Paroxysmal nocturnal hemoglobinuria (PNH)]] | |[[Paroxysmal nocturnal hemoglobinuria (PNH)]] | ||
|- | |- | ||
Revision as of 05:04, 22 April 2014
HemOnc.org - A Free Hematology/Oncology Reference
Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content.
Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. By using this site, you are indicating that you have read and agree with the terms set forth in the disclaimer. Initial priorities of this project will consist of:
- Creating a database of chemotherapy agents and other medications.
- Creating an index of diseases.
- Creating a collection of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
- Sample order sets and examples of supportive medications used with treatment regimens
- Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.
Additional possibilities for this project may include:
- Creating summaries of pivotal clinical trials
- Establishing homepages for ongoing clinical trials that contain information and sites of participation
- Checklists for common clinical scenarios/diseases
- Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects
- List of ICD-9 codes
- Being a source of reference documents
- Pathology references, including histology images and information about immunohistochemistry and CD markers.
The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.
If you would like to contribute, please create an account in the upper right corner, and send a message to [email protected] so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles.